Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04289623 · ClinicalTrials.gov registry record
Assessing the Impact of myHealth Rewards Program-related Communications on Enrollment: Replication
A clinical trial, sponsored by Geisinger Clinic.
- Completed
- Registry status
- 13,546
- Enrollment target
NCT04289623: Completed study, sponsored by Geisinger Clinic.
NCT04289623 is a clinical trial that has completed, run by Geisinger Clinic. The registered enrollment target is 13,546 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04289623 has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- 13,546 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate, prospectively, the potential impact on myHealth Rewards wellness program enrollment (prior to the 2020 deadline) of sending different messages via email to Geisinger Health Plan (GHP) members who have not yet enrolled. In particular, this study aims to replicate and extend (with greater sample size and statistical power) the findings from a previous study in which email communication using loss framing language achieved significantly higher click-through rates than a more standard communication, whereas actual enrollment rates were not significantly higher.
Primary Outcome
Enrollment in the myHealth Rewards program (yes/no) within 14 full days of the beginning of the intervention for each of the three waves.
Interventions
- BEHAVIORAL Email
- BEHAVIORAL Loss frame
- BEHAVIORAL Testimonial (medical expert)
- BEHAVIORAL Testimonial (rank-and-file)
- BEHAVIORAL Social norms (percentage)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,546 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2020-03-10 |
What the finished NCT04289623 record still lists
NCT04289623 is an observational study that tracks outcomes without assigning an intervention. Its 13,546 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which Email is the first listed.
NCT04289623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04289623 about?
NCT04289623 is a clinical study titled "Assessing the Impact of myHealth Rewards Program-related Communications on Enrollment: Replication". The purpose of the study is to evaluate, prospectively, the potential impact on myHealth Rewards wellness program enrollment (prior to the 2020 deadline) of sending different messages via email to Geisinger Health Plan (GHP) members who have not yet enrolled. In particular, this study aims to replic...
What is the current status of trial NCT04289623?
This trial is currently completed. The enrollment target is 13,546 participants. The study started on 2020-02-25. Estimated completion is 2020-03-10.
What interventions are being tested in trial NCT04289623?
The interventions under investigation include: Email (BEHAVIORAL), Loss frame (BEHAVIORAL), Testimonial (medical expert) (BEHAVIORAL), Testimonial (rank-and-file) (BEHAVIORAL), Social norms (percentage) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04289623?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI